NewsBenzingaMaxim Group Initiates Coverage On Mira Pharmaceuticals with Buy Rating, Announces Price Target of $3.5 Maxim Group Initiates Coverage On Mira Pharmaceuticals with Buy Rating, Announces Price Target of $3.5 Benzinga 2026.09.17 15:10 (GMT+0) Open on Benzinga Other news Apple, Meta And Jim Cramer Set the Tone for AI, iPhone and Vision Pro Moves: This Week in Apple Benzinga's 'Stock Whisper' Index: Five Stocks Investors Secretly Monitor But Don't Talk About Yet Account that profited $17 million from NEAR and INJ swaps MU, INTC, and DRAM for CBRS on Hyperliquid White House AI Task Force Puts Nvidia, Big Tech Under Regulatory Scrutiny - TipRanks.com Stifel Financial: Mid-Market Advisory And Commissions Could Resist Hikes (NYSE:SF) Paccar: The Price Has Come Down Far Enough Now (NASDAQ:PCAR)
